Abstract, Snapshot, Market Analysis & Market Definition: Recombinant Proteins Market
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression. Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018. Top 5 companies occupied 40% of the market. By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest. In 2018, the global Recombinant Proteins market size was 562 million US$ and it is expected to reach 969 million US$ by the end of 2025, with a CAGR of 0.081 during 2019-2025. This report focuses on the global Recombinant Proteins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Proteins development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Recombinant Proteins Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
OthersHormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research OrganizationsRecombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Recombinant Proteins Market
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Key Insights Covered: Exhaustive Recombinant Proteins Market
1. Market size (sales, revenue and growth rate) of Recombinant Proteins industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Recombinant Proteins industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Recombinant Proteins industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Recombinant Proteins industry.
Research Methodology: Recombinant Proteins Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.